Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Pharming Group N.V. (PHAR)

  • SEC News
  • Oct. 22, 2025, 13:37 UTC
  • 0
  • 0 comments

New Form 6-K - Pharming Group N.V. Filed: 2025-10-22 AccNo: 0001828316-25-000047 Size: 238 KB

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • SEC News
  • Oct. 22, 2025, 13:30 UTC
  • 0
  • 0 comments

New Form DEFA14A - AVADEL PHARMACEUTICALS PLC Filed: 2025-10-22 AccNo: 0001104659-25-101431 Size: 1 MB

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • SEC News
  • Oct. 22, 2025, 13:29 UTC
  • 0
  • 1 comments

(10% Negative) AVADEL PHARMACEUTICALS PLC (AVDL) Announces Business Combination

Comment Full text

Gemini Therapeutics Inc. (the company became a subdivision of the company Disc Medicine (NASDAQ : IRON)) (GMTX)

  • SEC News
  • Oct. 22, 2025, 13:11 UTC
  • 0
  • 1 comments

(99% Neutral) Disc Medicine, Inc. (GMTX) Announces Clinical Development Update

Comment Full text

Portage Biotech Inc. (PRTG)

  • SEC News
  • Oct. 22, 2025, 13:11 UTC
  • 0
  • 0 comments

New Form 424B3 - AlphaTON Capital Corp Filed: 2025-10-22 AccNo: 0001171843-25-006583 Size: 22 KB

Comment Full text

Alkermes plc (ALKS)

  • SEC News
  • Oct. 22, 2025, 13:09 UTC
  • 0
  • 1 comments

(10% Negative) Alkermes plc. (ALKS) Announces Business Combination

Comment Full text

Tourmaline Bio Inc (TRML)

  • SEC News
  • Oct. 22, 2025, 13:06 UTC
  • 0
  • 0 comments

New Form SC 14D9/A - Tourmaline Bio, Inc. Filed: 2025-10-22 AccNo: 0001104659-25-101420 Size: 15 KB

Comment Full text

Nurix Therapeutics Inc (NRIX)

  • SEC News
  • Oct. 22, 2025, 13:04 UTC
  • 0
  • 1 comments

(75% Positive) NURIX THERAPEUTICS, INC. (NRIX) Announces Enrollment Update for medicines Due to Patient Enrollment Issues, Regulatory Process, Safety Review

Comment Full text

Ikena Oncology (IKNA)

  • SEC News
  • Oct. 22, 2025, 13:03 UTC
  • 0
  • 1 comments

(99% Neutral) IMAGENEBIO, INC. (IKNA) Announces New Board Appointment

Comment Full text

Jazz Pharmaceuticals plc (JAZZ)

  • SEC News
  • Oct. 22, 2025, 13:01 UTC
  • 0
  • 1 comments

(99% Neutral) Jazz Pharmaceuticals plc (JAZZ) Announces Clinical Development Update

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(10260)
  • Event(1433)
  • SEC News(173903)
  • FDA Approval(9593)
  • Company Report(721)
  • Business News(116547)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin